查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1752111

全球人體肝臟模型市場：依產品類型、應用、最終用途及地區分析、規模、趨勢、預測（～2030年）

Global Human Liver Model Market: Analysis By Product Type, Application, By End-use, By Region Size and Trends with Forecast up to 2030
出版日期: | 出版商: Daedal Research | 英文 148 Pages | 訂單完成後即時交付

價格

人體肝臟模型是人體肝臟的科學和技術表徵，用於研究各種生理和病理條件下肝臟的結構、功能和行為。這些模型對於藥物研發、毒性測試、疾病建模、再生醫學和個人化醫療等應用非常重要。傳統的肝臟研究嚴重依賴動物模型和2D細胞培養，但這些方法往往無法準確重現人體肝臟的生理機能。全球人體肝臟模型市場規模預計2024年達到16.4億美元，預計2030年將達到38.1億美元。

全球人體肝臟模型市場主要受肝病盛行率上升的驅動，例如非酒精性脂肪性肝病（NAFLD/MASLD）、酒精性肝病（ALD）、病毒性肝炎和肝癌。器官列印技術（例如3D生物列印、器官晶片平台和類器官）的進步進一步推動了這項需求的成長。與傳統的2D細胞培養和動物模型相比，這些技術能夠創建更俱生理相關性和可預測性的人體肝臟模型。此外，由於倫理問題和物種固有差異導致無法準確預測藥物在人體中的安全性和有效性，人們強調減少對動物試驗的依賴，這大幅推動了人源性肝臟模型的採用。最後，對肝癌和其他肝病治療藥物的需求不斷成長，加上傳統藥物研發的高成本和失敗率，促使製藥和生物技術公司投資這些先進的模型，以實現更高效的藥物篩檢、毒性測試和個人化醫療方法。預計預測期內，即2025年至2030年，全球人體肝臟模型市場將以 15.03%的年複合成長率成長。

本報告對全球人體肝臟模型市場進行調查分析，包括成長動力和挑戰、市場趨勢和競爭格局。

目錄

第1章 執行摘要

第2章 簡介

  • 人體肝臟模型：概述
    • 人體肝臟模型簡介
    • 人體肝臟模型的優勢
  • 人體肝臟模型的區隔：概述
    • 人體肝臟模型的區隔

第3章 全球市場分析

  • 全球人體肝臟模型市場：分析
    • 全球人體肝臟模型市場：概況
    • 全球人體肝臟模型市場規模
    • 全球人體肝臟模型市場：依產品類型（2D人體肝臟模型、3D人體肝臟模型）
    • 全球人體肝臟模型市場：依應用（ADME 研究、毒性測試、疾病建模等）
    • 全球人體肝臟模型市場：依最終用途（製藥和生物技術公司、委外研發機構、學術和研究機構）
    • 全球人體肝臟模型市場：依地區（北美、歐洲、亞太地區、世界其他地區）
  • 全球人體肝臟模型市場：產品類型分析
    • 全球人體肝臟模型市場：依產品類型，概況
    • 全球2D人體肝臟模型市場規模
    • 全球2D人體肝臟模型市場：依產品類型（細胞株、原代人肝細胞）分類
    • 全球細胞株2D人體肝臟模型市場規模
    • 全球原代人類肝細胞2D人體肝臟模型市場規模
    • 全球3D人體肝臟模型市場規模
    • 全球3D人體肝臟模型市場：依產品類型（肝臟晶片、類器官、球體、3D 生物列印組織）
    • 肝臟晶片3D人體肝臟模型的全球市場規模
    • 全球類器官3D人體肝臟模型市場規模
    • 全球球體3D人體肝臟模型市場規模
    • 全球3D生物列印組織人體肝臟模型市場規模
  • 全球人體肝臟模型市場：應用分析
    • 全球人體肝臟模型市場應用概覽
    • ADME研究人體肝臟模型的全球市場規模
    • 用於毒性測試的人體肝臟模型的全球市場規模
    • 全球疾病建模人體肝臟模型市場規模
    • 全球其他人體肝臟模型市場規模
  • 全球人體肝臟模型市場：最終用途分析
    • 全球人體肝臟模型市場：依最終用途，概覽
    • 製藥和生物技術公司人體肝臟模型的全球市場規模
    • 委外研發機構人類肝臟模型的全球市場規模
    • 學術和研究機構人體肝臟模型的全球市場規模

第4章 區域市場分析

  • 北美人體肝臟模型市場：分析
    • 北美人體肝臟模型市場概況
    • 北美人體肝臟模型市場規模
    • 北美人體肝臟模型市場：依地區（美國、加拿大、墨西哥）
    • 美國人體肝臟模型市場規模
    • 加拿大人體肝臟模型市場規模
    • 墨西哥人體肝臟模型市場規模
  • 歐洲人體肝臟模型市場：分析
    • 歐洲人體肝臟模型市場概況
    • 歐洲人體肝臟模型市場規模
    • 歐洲人體肝臟模型市場：依地區（德國、英國、法國、義大利、西班牙、歐洲其他地區）
    • 德國人體肝臟模型市場規模
    • 英國人體肝臟模型市場規模
    • 法國人體肝臟模型市場規模
    • 義大利人體肝臟模型市場規模
    • 西班牙人體肝臟模型市場規模
    • 其他歐洲人體肝臟模型市場規模
  • 亞太人體肝臟模型市場：分析
    • 亞太地區人體肝臟模型市場概況
    • 亞太地區人體肝臟模型市場規模
    • 亞太人體肝臟模型市場（中國、日本、印度、韓國、亞太其他地區）
    • 中國人體肝臟模型市場規模
    • 日本人體肝臟模型市場規模
    • 印度人體肝臟模型的市場規模
    • 韓國人體肝臟模型市場規模
    • 其他亞太地區人體肝臟模型市場規模
  • 世界其他地區人體肝臟模型市場分析
    • 世界其他地區肝臟模型市場概況
    • 其他地區人體肝臟模型市場規模

第5章 市場動態

  • 成長動力
    • 肝病盛行率不斷上升
    • 對動物試驗替代品的需求日益成長
    • 對個人化醫療的興趣日益濃厚
    • 增加對肝臟研究的投資
    • 對藥物毒性早期診斷的需求日益增加
  • 課題
    • 肝臟模型成本高
    • 專業技能人才短缺
  • 市場趨勢
    • 人工智慧和機器學習整合
    • 器官列印和組織工程的進展
    • 從 2D 轉向先進的3D 離體模型
    • 混合模式和電腦模型的興起

第6章 競爭態勢

  • 全球人體肝臟模型市場公司：競爭格局
    • 全球人體肝臟模型市場公司：概述
  • 全球人體肝臟模型市場公司：最新發展

第7章 公司簡介

  • Corning Incorporated
  • Organovo Holdings Inc.
  • InSphero AG
  • BioIVT LLC
  • Emulate Inc.
  • MatTek（The BICO Group）
  • MIMETAS
  • CN Bio Innovations Ltd.
  • Cyfuse Biomedical KK
  • PhoenixBio Co., Ltd.
  • STEMCELL Technologies
  • Pandorum Technologies Pvt. Ltd.
  • Kirkstall Ltd.

The human liver model is a scientific and technological representation of the human liver that is used to study its structure, function, and behavior in various physiological and pathological conditions. These models are crucial for applications in drug discovery, toxicology testing, disease modeling, regenerative medicine, and personalized healthcare. Traditional liver research relied heavily on animal models and 2D cell cultures, but these approaches often fall short of accurately replicating human liver physiology. The global human liver model market value in 2024 stood at US$1.64 billion, and is projected to reach US$3.81 billion by 2030.

The global human liver model market is primarily driven by the increasing prevalence of liver diseases such as non-alcoholic fatty liver disease (NAFLD/MASLD), alcoholic liver disease (ALD), viral hepatitis, and liver cancer. This growing demand is further propelled by advancements in organ printing technologies like 3D bioprinting, organ-on-a-chip platforms, and organoids, which allow for the creation of more physiologically relevant and predictive human liver models compared to traditional 2D cell cultures or animal models. Additionally, a strong emphasis on reducing reliance on animal testing due to ethical concerns and the inherent species differences that often lead to inaccurate drug safety and efficacy predictions in humans, significantly boosts the adoption of human-derived liver models. Finally, the increasing demand for therapeutic drugs for liver cancer and other liver conditions, coupled with the high costs and failure rates associated with conventional drug discovery, incentivizes pharmaceutical and biotechnology companies to invest in these advanced models for more efficient drug screening, toxicity testing, and personalized medicine approaches. The global human liver model market value is projected to grow at a CAGR of 15.03%, during the forecast period of 2025-2030.

Market Segmentation Analysis:

By Product Type: According to the report, based on product type, the global human liver model market can be divided into two segments: 2D human liver model and 3D human liver model. 2D human liver model segment is further segmented based on product as cell lines and primary human hepatocytes and 3D human liver model segment is bifurcated as liver-on-a-chip, organoids, spheroids and 3D bio printed tissues. 2D human liver model segment acquired majority of share in the market in 2024 primarily due to its cost-effectiveness, simplicity, and well-established protocols. Many researchers still rely on 2D models for high-throughput screening and initial drug toxicity testing, where their efficiency and reliability provided a practical solution despite their limitations in fully replicating in vivo conditions. However, the 3D human liver model segment is expected to grow the fastest because these models offer significantly enhanced physiological relevance, better mimicking the complex architecture, cell-cell interactions, and metabolic functions of a real human liver compared to 2D cultures. This improved accuracy leads to more reliable predictions in drug discovery, toxicity testing, and disease modeling, reducing late-stage drug failures and the need for animal testing. As technologies like 3D bioprinting and organ-on-a-chip mature and become more accessible, their capacity for higher throughput and scalability is also increasing, making them increasingly attractive for pharmaceutical and biotechnology companies seeking more predictive and human-relevant research tools.

By Application: According to the report, based on application, the global human liver model market can be divided into four segments: ADME Studies, toxicology testing, disease modeling and others. ADME segment acquired majority of share in the market in 2024 because these studies are critical and often mandated early steps in drug development. By using human liver models for ADME studies, pharmaceutical companies can more accurately simulate human physiological conditions, allowing them to filter out unsuitable drug candidates earlier in the costly and time-consuming drug discovery pipeline, thereby saving significant resources and accelerating drug development. Meanwhile, the toxicology testing segment is expected to grow the fastest during the forecasted period, driven by rising concern about drug-induced liver injury (DILI) and other organ toxicities, leading to increased demand for robust preclinical models that can accurately predict adverse effects in humans. Secondly, stricter regulatory guidelines worldwide are pushing pharmaceutical companies to conduct more comprehensive and reliable toxicity assessments earlier in the drug development pipeline. Finally, the limitations and ethical concerns associated with traditional animal testing are driving a shift towards more human-relevant in vitro models, like the advanced 3D liver models, for more accurate and predictive toxicology screens.

By End-use: According to the report, the global human liver model market is bifurcated into three types of end-uses: pharmaceutical & biotechnology companies, contract research organizations, and academic and research institutes. Pharmaceutical & biotechnology companies segment acquired the majority share in the global human liver model market in 2024 because they are the primary drivers of drug discovery and development. These companies heavily rely on human liver models for crucial preclinical studies, including assessing drug metabolism (ADME), evaluating drug-drug interactions, and, most importantly, identifying potential hepatotoxicity. The ability of these models to more accurately predict human physiological responses, thereby reducing costly failures in later clinical trial stages, makes them indispensable tools for pharmaceutical and biotech firms striving for efficient and safer drug development. However, CROs are projected for the fastest growth as pharmaceutical and biotech companies increasingly outsource R&D to leverage specialized expertise, advanced technologies, and cost efficiencies. This allows them to accelerate drug development and manage resources more effectively without the need for significant in-house investment in complex human liver model platforms.

By Region: The report provides insight into the human liver model market based on the geographical operations, namely, North America, Europe, Asia Pacific and Rest of the World. North America human liver model market enjoyed the highest market share in 2024 due to its robust healthcare infrastructure, significant R&D expenditure by pharmaceutical and biotechnology companies, and a favorable regulatory environment supporting advanced preclinical testing. Meanwhile, Asia Pacific is projected for the fastest growth driven by increasing investments in medical research, a burgeoning biotech industry, rising prevalence of liver diseases, and improving healthcare infrastructure across the region.

Global Human liver model Market Dynamics:

Growth Drivers: One of the most important factors driving the growth of the global human liver model market is is the increasing prevalence of liver diseases worldwide. Conditions like non-alcoholic fatty liver disease (NAFLD/MASLD), alcoholic liver disease (ALD), viral hepatitis, and liver cancer are on the rise globally due to lifestyle changes and other factors. This escalating disease burden creates an urgent and growing demand for more accurate, human-relevant research tools to better understand disease mechanisms, develop effective therapies, and conduct efficient drug discovery and toxicity testing. Other factors driving the growth of global human liver model market include growing demand for alternatives to animal testing, increasing focus on personalized medicine, growing investment in liver research, the growing need for early drug toxicity diagnosis etc.

Challenges: One significant challenge faced by the global human liver model market is the high cost and technical complexity associated with developing and maintaining advanced 3D models. While these models offer superior physiological relevance, their creation often requires specialized equipment, skilled personnel, and significant financial investment. This complexity can limit their accessibility and scalability, particularly for smaller research institutions or companies, hindering widespread adoption despite their clear advantages over traditional 2D systems.

Trends: A major trend that will further drive the growth of the global human liver model market is the advancement and increasing adoption of 3D bioprinting and organ-on-a-chip technologies. These innovations are enabling the creation of more sophisticated, physiologically relevant, and high-throughput human liver models that better mimic in-vivo conditions. This improved accuracy leads to more reliable data in drug discovery, toxicity testing, and disease modeling, ultimately accelerating the development of safer and more effective treatments while reducing reliance on traditional, less predictive methods. The market is also projected to grow at a fast pace during the forecast period, due to various other latest trends such as integration of AI and machine learning, advancements in organ printing and tissue engineering technologies, shift from 2D to advanced 3D and ex vivo models, rise of hybrid and in silico models etc.

Competitive Landscape and Recent Developments:

The global human liver model market currently presents a moderately fragmented competitive landscape, although it is showing clear signs of moving towards consolidation, particularly within its more technologically advanced segments. The fragmentation stems from rapid pace of innovation in tissue engineering, microfluidics, and stem cell biology continually giving rise to new biotech startups. Regional market differences and the significant contributions from academic research also contribute to this distributed competitive environment. However, consolidation is evident in the dominance of a few key players in the cutting-edge 3D model segments (like InSphero, CN Bio Innovations, and Emulate), who possess strong patent portfolios and are often preferred partners for large pharmaceutical companies. This trend is further driven by strategic mergers and acquisitions (M&A) and increasing partnerships, as larger entities seek to integrate specialized technologies and expertise. Key players of global human liver model market are:

Organovo Holdings

InSphero

BioIVT LLC

Emulate Inc.

MatTek

Mimetas

CN Bio Innovations Ltd.

Cyfuse Biomedical KK

Corning Incorporated

Pheonix Bio

Stemcell Technologies

Pandorum Technologies

Kirkstall Ltd

The key players are constantly investing in strategic initiatives, such as adoption of new technologies, introducing their products to emerging markets and more, to maintain a competitive edge in this market. For instance, In February 2025, CN Bio launched the PhysioMimix(R) DILI assay kit: Human 24, an all-in-one kit providing rapid access to their FDA-recognized human Drug-Induced Liver Injury (DILI) assay. This kit streamlines workflows and allows users to assess up to eight conditions simultaneously, leveraging their highly functional and metabolically active liver microphysiological system (MPS).

Table of Contents

1. Executive Summary

2. Introduction

  • 2.1 Human Liver Model: An Overview
    • 2.1.1 Introduction to Human Liver Model
    • 2.1.2 Benefits of Human Liver Model
  • 2.2 Human Liver Model Segmentation: An Overview
    • 2.2.1 Human Liver Model Segmentation

3. Global Market Analysis

  • 3.1 Global Human Liver Model Market: An Analysis
    • 3.1.1 Global Human Liver Model Market: An Overview
    • 3.1.2 Global Human Liver Model Market by Value
    • 3.1.3 Global Human Liver Model Market by Product Type (2D Human Liver Model and 3D Human Liver Model)
    • 3.1.4 Global Human Liver Model Market by Application (ADME Studies, Toxicology Testing, Disease Modeling and Others)
    • 3.1.5 Global Human Liver Model Market by End-use (Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Academic and Research Institutes)
    • 3.1.6 Global Human Liver Model Market by Region (North America, Europe, Asia Pacific and Rest of the World)
  • 3.2 Global Human Liver Model Market: Product Type Analysis
    • 3.2.1 Global Human Liver Model Market by Product Type: An Overview
    • 3.2.2 Global 2D Human Liver Model Market by Value
    • 3.2.3 Global 2D Human Liver Model Market by Product Type (Cell Lines and Primary Human Hepatocytes)
    • 3.2.4 Global Cell Lines 2D Human Liver Model Market by Value
    • 3.2.5 Global Primary Human Hepatocytes 2D Human Liver Model Market by Value
    • 3.2.6 Global 3D Human Liver Model Market by Value
    • 3.2.7 Global 3D Human Liver Model Market by Product Type (Liver-on-a-chip, Organoids, Spheroids and 3D bio printed tissues)
    • 3.2.8 Global Liver-on-a-chip 3D Human Liver Model Market by Value
    • 3.2.9 Global Organoids 3D Human Liver Model Market by Value
    • 3.2.10 Global Spheroids 3D Human Liver Model Market by Value
    • 3.2.11 Global 3D Bio printed Tissues Human Liver Model Market by Value
  • 3.3 Global Human Liver Model Market: Application Analysis
    • 3.3.1 Global Human Liver Model Market by Application: An Overview
    • 3.3.2 Global ADME Studies Human Liver Model Market by Value
    • 3.3.3 Global Toxicology Testing Human Liver Model Market by Value
    • 3.3.4 Global Disease Modeling Human Liver Model Market by Value
    • 3.3.5 Global Others Human Liver Model Market by Value
  • 3.4 Global Human Liver Model Market: End-use Analysis
    • 3.4.1 Global Human Liver Model Market by End-use: An Overview
    • 3.4.2 Global Pharmaceutical & Biotechnology Companies Human Liver Model Market by Value
    • 3.4.3 Global Contract Research Organizations Human Liver Model Market by Value
    • 3.4.4 Global Academic and Research Institutes Human Liver Model Market by Value

4. Regional Market Analysis

  • 4.1 North America Human Liver Model Market: An Analysis
    • 4.1.1 North America Human Liver Model Market: An Overview
    • 4.1.2 North America Human Liver Model Market by Value
    • 4.1.3 North America Human Liver Model Market by Region (The US, Canada and Mexico)
    • 4.1.4 The US Human Liver Model Market by Value
    • 4.1.5 Canada Human Liver Model Market by Value
    • 4.1.6 Mexico Human Liver Model Market by Value
  • 4.2 Europe Human Liver Model Market: An Analysis
    • 4.2.1 Europe Human Liver Model Market: An Overview
    • 4.2.2 Europe Human Liver Model Market by Value
    • 4.2.3 Europe Human Liver Model Market by Region (Germany, UK, France, Italy, Spain and Rest of Europe)
    • 4.2.4 Germany Human Liver Model Market by Value
    • 4.2.5 United Kingdom Human Liver Model Market by Value
    • 4.2.6 France Human Liver Model Market by Value
    • 4.2.7 Italy Human Liver Model Market by Value
    • 4.2.8 Spain Human Liver Model Market by Value
    • 4.2.9 Rest of Europe Human Liver Model Market by Value
  • 4.3 Asia Pacific Human Liver Model Market: An Analysis
    • 4.3.1 Asia Pacific Human Liver Model Market: An Overview
    • 4.3.2 Asia Pacific Human Liver Model Market by Value
    • 4.3.3 Asia Pacific Human Liver Model Market by Region (China, Japan, India, South Korea and Rest of Asia Pacific)
    • 4.3.4 China Human Liver Model Market by Value
    • 4.3.5 Japan Human Liver Model Market by Value
    • 4.3.6 India Human Liver Model Market by Value
    • 4.3.7 South Korea Human Liver Model Market by Value
    • 4.3.8 Rest of Asia Pacific Human Liver Model Market by Value
  • 4.4 Rest of the World Human Liver Model Market: An Analysis
    • 4.4.1 Rest of the World Human Liver Model Market: An Overview
    • 4.4.2 Rest of the World Human Liver Model Market by Value

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Increasing Prevalence of Liver Diseases
    • 5.1.2 Growing Demand for Alternatives to Animal Testing
    • 5.1.3 Increasing Focus on Personalized Medicine
    • 5.1.4 Growing Investment in Liver Research
    • 5.1.5 The Growing Need for Early Drug Toxicity Diagnosis
  • 5.2 Challenges
    • 5.2.1 High Cost of Liver Models
    • 5.2.2 Dearth of Skilled Professionals
  • 5.3 Market Trends
    • 5.3.1 Integration of AI and Machine Learning
    • 5.3.2 Advancements in Organ Printing and Tissue Engineering Technologies
    • 5.3.3 Shift from 2D to Advanced 3D and Ex Vivo Models
    • 5.3.4 Rise of Hybrid and In Silico Models

6. Competitive Landscape

  • 6.1 Global Human Liver Model Market Players: Competitive Landscape
    • 6.1.1 Global Human Liver Model Market Players: An Overview
  • 6.2 Global Human Liver Model Market Players: Recent Developments

7. Company Profiles

  • 7.1 Corning Incorporated
    • 7.1.1 Business Overview
    • 7.1.2 Operating Segments
    • 7.1.3 Business Strategies
  • 7.2 Organovo Holdings Inc.
    • 7.2.1 Business Overview
    • 7.2.2 Business Strategies
  • 7.3 InSphero AG
    • 7.3.1 Business Overview
    • 7.3.2 Business Strategies
  • 7.4 BioIVT LLC
    • 7.4.1 Business Overview
    • 7.4.2 Business Strategies
  • 7.5 Emulate Inc.
    • 7.5.1 Business Overview
    • 7.5.2 Business Strategies
  • 7.6 MatTek (The BICO Group)
    • 7.6.1 Business Overview
    • 7.6.2 Business Strategies
  • 7.7 MIMETAS
    • 7.7.1 Business Overview
    • 7.7.2 Business Strategies
  • 7.8 CN Bio Innovations Ltd.
    • 7.8.1 Business Overview
    • 7.8.2 Business Strategies
  • 7.9 Cyfuse Biomedical K.K.
    • 7.9.1 Business Overview
    • 7.9.2 Business Strategies
  • 7.10 PhoenixBio Co., Ltd.
    • 7.10.1 Business Overview
    • 7.10.2 Business Strategies
  • 7.11 STEMCELL Technologies
    • 7.11.1 Business Overview
    • 7.11.2 Business Strategies
  • 7.12 Pandorum Technologies Pvt. Ltd.
    • 7.12.1 Business Overview
  • 7.13 Kirkstall Ltd.
    • 7.13.1 Business Overview

List of Figures

  • Figure 1: Benefits of Human Liver Model
  • Figure 2: Human Liver Model Segmentation
  • Figure 3: Global Human Liver Model Market by Value; 2020-2024 (US$ Billion)
  • Figure 4: Global Human Liver Model Market by Value; 2025-2030 (US$ Billion)
  • Figure 5: Global Human Liver Model Market by Product Type; 2024 (Percentage, %)
  • Figure 6: Global Human Liver Model Market by Application; 2024 (Percentage, %)
  • Figure 7: Global Human Liver Model Market by End-use; 2024 (Percentage, %)
  • Figure 8: Global Human Liver Model Market by Region; 2024 (Percentage, %)
  • Figure 9: Global 2D Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 10: Global 2D Human Liver Model Market by Value; 2025-2030 (US$ Billion)
  • Figure 11: Global 2D Human Liver Model Market by Product Type; 2024 (Percentage, %)
  • Figure 12: Global Cell Lines 2D Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 13: Global Cell Lines 2D Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 14: Global Primary Human Hepatocytes 2D Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 15: Global Primary Human Hepatocytes 2D Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 16: Global 3D Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 17: Global 3D Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 18: Global Human Liver Model Market by Product Type; 2024 (Percentage, %)
  • Figure 19: Global Liver-on-a-chip 3D Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 20: Global Liver-on-a-chip 3D Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 21: Global Organoids 3D Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 22: Global Organoids 3D Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 23: Global Spheroids 3D Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 24: Global Spheroids 3D Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 25: Global 3D Bio printed Tissues Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 26: Global 3D Bio printed Tissues Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 27: Global ADME Studies Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 28: Global ADME Studies Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 29: Global Toxicology Testing Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 30: Global Toxicology Testing Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 31: Global Disease Modeling Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 32: Global Disease Modeling Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 33: Global Others Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 34: Global Others Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 35: Global Pharmaceutical & Biotechnology Companies Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 36: Global Pharmaceutical & Biotechnology Companies Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 37: Global Contract Research Organizations Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 38: Global Contract Research Organizations Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 39: Global Academic and Research Institutes Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 40: Global Academic and Research Institutes Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 41: North America Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 42: North America Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 43: North America Human Liver Model Market by Region; 2024 (Percentage, %)
  • Figure 44: The US Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 45: The US Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 46: Canada Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 47: Canada Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 48: Mexico Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 49: Mexico Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 50: Europe Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 51: Europe Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 52: Europe Human Liver Model Market by Region; 2024 (Percentage, %)
  • Figure 53: Germany Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 54: Germany Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 55: United Kingdom Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 56: United Kingdom Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 57: France Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 58: France Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 59: Italy Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 60: Italy Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 61: Spain Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 62: Spain Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 63: Rest of Europe Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 64: Rest of Europe Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 65: Asia Pacific Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 66: Asia Pacific Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 67: Asia Pacific Human Liver Model Market by Region; 2024 (Percentage, %)
  • Figure 68: China Human Liver Model Market by Value, 2020-2024 (US$ Million)
  • Figure 69: China Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 70: Japan Human Liver Model Market by Value, 2020-2024 (US$ Million)
  • Figure 71: Japan Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 72: India Human Liver Model Market by Value, 2020-2024 (US$ Million)
  • Figure 73: India Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 74: South Korea Human Liver Model Market by Value, 2020-2024 (US$ Million)
  • Figure 75: South Korea Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 76: Rest of Asia Pacific Human Liver Model Market by Value, 2020-2024 (US$ Million)
  • Figure 77: Rest of Asia Pacific Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 78: Rest of the World Human Liver Model Market by Value; 2020-2024 (US$ Million)
  • Figure 79: Rest of the World Human Liver Model Market by Value; 2025-2030 (US$ Million)
  • Figure 80: Global Artificial Intelligence (AI) in Healthcare Market; 2021-2030 (US$ Billion)
  • Figure 81: Corning Incorporated Net Sales by Segments; 2024 (Percentage, %)